Ocular Comfort and Inflammation in Lid Hygiene Therapy
|ClinicalTrials.gov Identifier: NCT02938078|
Recruitment Status : Unknown
Verified October 2016 by Minnesota Eye Consultants, P.A..
Recruitment status was: Recruiting
First Posted : October 19, 2016
Last Update Posted : October 19, 2016
|Condition or disease||Intervention/treatment||Phase|
|Blepharitis||Device: Avenova Lid Cleanser||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Ocular Comfort and Markers of Inflammation in Subjects Undergoing Lid Hygiene Therapy|
|Study Start Date :||October 2016|
|Estimated Primary Completion Date :||May 2017|
Experimental: Treatment Eye
One eye will be treated with Avenova; the other eye will not be treated. The investigator is masked as to which eye is receiving Avenova product.
Device: Avenova Lid Cleanser
Avenova lid cleanser is an FDA-cleared saline solution preserved with 0.01% pure hypochlorous acid.
No Intervention: Non-Treatment Eye
One eye will be treated with Avenova; the other eye will not will be treated. The investigator is masked as to which eye is receiving Avenova product.
- Reduction in Severity of Markers of Inflammation [ Time Frame: 30 days ]
- Change in Ocular Discomfort [ Time Frame: 30 days ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02938078
|Contact: Erich J Berg, BAemail@example.com|
|United States, Minnesota|
|Minnesota eye Consultants, PA||Recruiting|
|Bloomington, Minnesota, United States, 55431|
|Contact: Erich J Berg, Ba 952-567-6111 firstname.lastname@example.org|
|Principal Investigator: Ahmad M. Fahmy, OD|
|Principal Investigator:||Ahmad M Fahmy, OD||Minnesota Eye Consultants|